|
|||||
AvaproActive Ingredient(s): IrbesartanFirst Approved by the FDA: September 30, 1997 Pharmaceutical Company: SANOFI AVENTIS US Avapro Article SummaryIrbesartan (inn) (pronounced /rbsrtn/) Is An Angiotensin Ii Receptor Antagonist Used Mainly For The Treatment Of Hypertension. Irbesartan Was Developed By Sanofi Research (now Part Of Sanofi-aventis). It Is Jointly Marketed By Sanofi-aventis And Bristol-myers Squibb Under The Trade Names Aprovel, Karvea, And Avapro. contents 1 Clinical Use 1.1 Indications 1.2 Combination With Diuretic 2 No Benefits Seen For 3 Market 4 References 5 See Also // clinical Use main Article: Angio ... Read the Full Avapro ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Avapro Recent Avapro Forums Start a New Discussion View All
|
|||||
Home Page
Follow Us On Twitter
Registered Community Experts
|
||||
Graphical Link HTML Code:
Text Link: Learn About Avapro
Text Link HTML Code:
Return to Top
Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for face to face medical advice from a qualified healthcare professional. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved.
Drugs/Avapro.asp Last Updated July 2 2006
